Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 vs HGH Therapy Mechanism: Research Application Comparison

Primary Mechanism Binds GHRH receptors on pituitary somatotrophs → upregulates endogenous GH synthesis and pulsatile release Exogenous bioidentical GH enters circulation directly → binds GH receptors on target tissues, bypassing pituitary CJC-1295 amplifies na

This comparison does not assign a generated winner or score.

  • Primary Mechanism
  • Binds GHRH receptors on pituitary somatotrophs → upregulates endogenous GH synthesis and pulsatile release
  • Exogenous bioidentical GH enters circulation directly → binds GH receptors on target tissues, bypassing pituitary
  • CJC-1295 amplifies natural secretion rhythm; rhGH replaces it entirely
  • Half-Life & Dosing
  • 6–8 days (with DAC modification). Once weekly administration maintains effect
  • 2.5–4 hours. Requires daily or twice-daily injections for sustained elevation
  • Weekly dosing simplifies compliance; daily rhGH injections offer tighter pharmacokinetic control
  • IGF-1 Elevation Pattern
  • Pulsatile peaks (1.5–2.5× baseline). Maintains circadian variation
  • Sustained elevation (2–4× baseline). Flattened across 24-hour cycle at therapeutic doses
  • Pulsatile IGF-1 better preserves insulin sensitivity; sustained elevation accelerates tissue effects
  • Feedback Loop Impact
  • Preserves somatostatin-mediated inhibition. Pituitary function maintained
  • Suppresses endogenous GH secretion via negative feedback. Pituitary atrophy over extended use
  • CJC-1295 suitable for long-term protocols requiring preserved endogenous capacity
  • Typical Research Dose Range
  • 1–2 mg per week (split or single dose depending on protocol design)
  • 0.3–0.6 mg/day for metabolic research; 2–4 IU/day (0.67–1.33 mg) for anabolic studies
  • Dose comparison not 1:1. Mechanisms too different to equate directly
  • Primary Use Case in Research
  • Protocols requiring physiological GH rhythm preservation, long-term metabolic studies, anti-aging models
  • Acute anabolic studies, GH deficiency replacement models, controlled IGF-1 elevation experiments
  • Choose based on whether research design benefits from feedback preservation or pharmacokinetic precision
More references

Related material